The preanalytical phase in hematopathology: sampling as a critical step for an appropriate diagnosis. A position paper from the Italian Group of Haematopathology (GIE)
Lymphoma diagnosis relies on morphological, immunophenotypical and molecular analyses of lesional tissue biopsies. Expert guidelines recommend surgical excision biopsy (SEB) of lymph nodes as the standard approach, as it provides adequate tissue for definitive diagnosis, accurate subtyping, and treatment selection, but core needle biopsy (CNB) is increasingly used in clinical practice because of its practical advantages. However, a critical analysis of most published series reveals that CNB may have lower diagnostic accuracy than SEB, with a high risk of inadequate/insufficient material and tissue artifacts, leading to non-definitive diagnoses and lymphoma subtype misclassification, which may delay diagnosis and/or adversely affect clinical management. The limited tissue obtained by CNB may hinder lesional architectural assessment and comprehensive ancillary testing, particularly when tissue is rapidly exhausted. In contrast, SEB generally provides more tissue for diagnostic evaluation, also favoring biobanking for future diagnostic and therapeutic needs and research purposes. We believe that SEB remains the preferred approach for accurate lymphoma characterization and subtyping when feasible. SEB and CNB should be considered complementary rather than mutually exclusive approaches, with CNB particularly useful in patients at increased surgical risk or presenting with deep-seated, surgically inaccessible lesions. When CNB results are inconclusive or discordant with clinical findings, repeat sampling, preferably by SEB whenever possible, should be recommended to establish a reliable diagnosis. Regardless of the sampling approach, careful tissue handling and appropriate pre-analytical procedures remain essential to ensure both the quality and the sustainability of the histopathological diagnostic process.
Authors
- Marco Paulli (ORCID: https://orcid.org/0000-0003-2454-5980)
- Maurilio Ponzoni (ORCID: https://orcid.org/0000-0002-0055-325X)
- Arianna Di Napoli (ORCID: https://orcid.org/0000-0002-3159-5380)
- Stefano Lazzi (ORCID: https://orcid.org/0000-0002-2218-3771)
- Stefano Aldo Pileri (ORCID: https://orcid.org/0000-0001-8032-5128)
- Ada Maria Florena (ORCID: https://orcid.org/0000-0002-5450-0890)
- Umberto Gianelli (ORCID: https://orcid.org/0000-0003-3304-8417)
- Gaia Goteri (ORCID: https://orcid.org/0000-0001-5198-8387)
- Elena Sabattini (ORCID: https://orcid.org/0000-0002-4136-3591)
- Marco Lucioni (ORCID: https://orcid.org/0000-0002-6244-3646)
- Stefano Ascani (ORCID: https://orcid.org/0000-0002-4516-9040)
- Fabio Facchetti (ORCID: https://orcid.org/0000-0003-4975-2388)
- Raffaella Santi (ORCID: https://orcid.org/0009-0005-5317-7533)
- Claudio Tripodo (ORCID: https://orcid.org/0000-0002-0821-6231)
- Claudio Agostinelli (ORCID: https://orcid.org/0000-0002-4945-1422)
- Emanuele S.G. dʼAmore (ORCID: https://orcid.org/0000-0003-2229-5973)
Institutions
- University of Siena (IT)
- Marche Polytechnic University (IT)
- University of Milan (IT)
- University of Pavia (IT)
- University of Perugia (IT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- IFOM (IT)
- Azienda Ospedaliera S.Maria (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- IRCCS Ospedale San Raffaele (IT)
- Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo (IT)
- University of Florence (IT)
- European Institute of Oncology (IT)
- University of Brescia (IT)
- Sapienza University of Rome (IT)
- University of Palermo (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Haematologica
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3324/haematol.2026.301310
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00